The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for the last decade. The revised DLB consensus criteria now distinguish clearly between clinical features and diagnostic biomarkers, and give guidance about optimal methods to establish and interpret these. Substantial new information has been incorporated about previously reported aspects of DLB, with increased diagnostic weighting given to REM sleep behavior disorder and 123iodine-metaiodobenzylguanidine (MIBG) myocardial scintigraphy. The diagnostic role of other neuroimaging, electrophysiologic, and laboratory investigations is also described. Minor modifications to pathologic methods and criteria are recommended to take account of Alzheimer disease neuropathologic change, to add previously omitted Lewy-related pathology categories, and to include assessments for substantia nigra neuronal loss. Recommendations about clinical management are largely based upon expert opinion since randomized controlled trials in DLB are few. Substantial progress has been made since the previous report in the detection and recognition of DLB as a common and important clinical disorder. During that period it has been incorporated into DSM-5, as major neurocognitive disorder with Lewy bodies. There remains a pressing need to understand the underlying neurobiology and pathophysiology of DLB, to develop and deliver clinical trials with both symptomatic and disease-modifying agents, and to help patients and carers worldwide to inform themselves about the disease, its prognosis, best available treatments, ongoing research, and how to get adequate support.

We propose to explain shear thinning behaviour observed in most concentrated non-Brownian suspensions by variable friction between particles. Considering the low magnitude of the forces experienced by the particles of suspensions under shear flow, it is first argued that rough particles come into solid contact through one or a few asperities. In such a few-asperity elastic-plastic contact, the friction coefficient is expected not to be constant but to decrease with increasing normal load. Simulations based on the Force Coupling Method and including such a load-dependent friction coefficient are performed for various particle volume fractions. The results of the numerical simulations are compared to viscosity measurements carried out on suspensions of polystyrene particles (40 µm in diameter) dispersed in a Newtonian silicon oil. The agreement is shown to be satisfactory. Furthermore, the comparison between the simulations conducted either with a constant or a load-dependent friction coefficient provides a model for the shearthinning viscosity. In this model the effective friction coefficient µ ef f is specified by the effective normal contact force which is simply proportional to the bulk shear stress. As the shear stress increases, µ ef f decreases and the jamming volume fraction increases, leading to the reduction of the viscosity. At last, using this model, we show that it is possible to evaluate the microscopic friction coefficient for each applied shear stress from the rheometric measurements.

No abstract

Plasma Aβ was associated with cognitive status and CSF biomarkers, suggesting the interest of plasma amyloid biomarkers for diagnosis purpose.